The Wire Science@TheWireScience
India’s Biological E. Ltd will soon start phase 3 clinical trials of its COVID-19 vaccine and plans producing 75 mi… https://t.co/9sNotv7bNI
After Covaxin and Covishield, the Sputnik V vaccine was the third approved for use in India. The first consignment… https://t.co/02kIdh9byy
"I don’t think viruses go by weekend or week or day or night. We have to take more strict measures, I don’t know wh… https://t.co/Ug9Eh5wekF
Between the hospital bed shortage and the horrifying oxygen shortage, vaccines have offered a ray of hope – even as… https://t.co/ovP30B8hdm
Tree-killing microorganisms like the microfungus responsible for Dutch elm disease have been criss-crossing the wor… https://t.co/zZQLyXofi2
